Published in Appl Microbiol on June 01, 1972
The life and times of the Enterococcus. Clin Microbiol Rev (1990) 16.58
Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol (1989) 13.84
Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17
Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23
Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17
DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol (1991) 5.86
Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest (1983) 5.59
Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother (1989) 5.28
Species identities of enterococci isolated from clinical specimens. J Clin Microbiol (1990) 4.54
Presumptive speciation of Streptococcus bovis and other group D streptococci from human sources by using arginine and pyruvate tests. J Clin Microbiol (1975) 4.27
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother (1980) 3.54
Identification of streptococci: use of lysozyme and Streptomyces albus filtrate in the preparation of extracts for Lancefield grouping. J Clin Microbiol (1975) 3.53
High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother (1979) 3.42
Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin. Antimicrob Agents Chemother (1977) 3.27
Drug resistance in group D streptococci of clinical and nonclinical origin: prevalence, transferability, and plasmid properties. Antimicrob Agents Chemother (1977) 3.19
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95
Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides. Antimicrob Agents Chemother (1983) 2.88
Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin. Antimicrob Agents Chemother (1973) 2.83
Presumptive identification of group A, B, and D streptococci on agar plate media. J Clin Microbiol (1979) 2.72
Microbiological study of streptococcal bacteremia. Appl Microbiol (1973) 2.70
Classification and identification of the viridans streptococci. Clin Microbiol Rev (1989) 2.70
Resistance to beta-lactam antibiotics in Streptococcus faecium. Antimicrob Agents Chemother (1982) 2.68
Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1991) 2.68
Use of fecal streptococci as indicators of pollution in soil. Appl Environ Microbiol (1978) 2.43
Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol (1989) 2.43
High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections. J Clin Microbiol (1987) 2.42
Susceptibilities of enterococci to twelve antibiotics. Antimicrob Agents Chemother (1984) 2.13
Use of the Rapid STREP system for identification of viridans streptococcal species. J Clin Microbiol (1983) 2.02
Association of Streptococcus bovis bacteremia with bowel disease. J Clin Microbiol (1983) 2.01
Identification of viridans streptococci isolated from clinical specimens. J Clin Microbiol (1982) 1.98
Disseminated tetracycline resistance in oral streptococci: implication of a conjugative transposon. Infect Immun (1984) 1.96
Plasmid-mediated resistance to antibiotic synergism in enterococci. J Clin Invest (1978) 1.90
Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol (1984) 1.81
Detection of group D and viridans streptococci in blood by radiometric methods. J Clin Microbiol (1979) 1.79
Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol (1992) 1.67
Transferable plasmids mediating multiple-antibiotic resistance in Streptococcus faecalis subsp. liquefaciens. Antimicrob Agents Chemother (1977) 1.64
Occurrence of Streptococcus milleri among beta-hemolytic streptococci isolated from clinical specimens. J Clin Microbiol (1985) 1.64
Identification of Enterococcus spp. with a biochemical key. Appl Environ Microbiol (1999) 1.61
Identification of Streptococcus bovis and Streptococcus salivarius in clinical laboratories. J Clin Microbiol (1984) 1.60
Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol (2008) 1.53
Antibiotic-induced lysis of enterococci. J Clin Invest (1981) 1.49
The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg (1990) 1.48
High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis), and viridans streptococci. Antimicrob Agents Chemother (1982) 1.47
Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother (1984) 1.45
Conjugative R plasmids in Streptococcus faecium (group D). Antimicrob Agents Chemother (1982) 1.35
Fluorogenic selective and differential medium for isolation of fecal streptococci. Appl Environ Microbiol (1983) 1.35
Autograft rejection in acutely burned patients: relation to colonization by Streptococcus agalactiae. Appl Microbiol (1973) 1.34
Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants. J Clin Microbiol (1998) 1.34
Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents. Appl Environ Microbiol (1982) 1.34
Bacteria isolated from the duodenum, ileum, and cecum of young chicks. Appl Environ Microbiol (1978) 1.33
Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.30
Evaluation of selective media for enumeration of group D streptococci in bovine feces. Appl Microbiol (1974) 1.26
Paradoxical response of Enterococcus faecalis to the bactericidal activity of penicillin is associated with reduced activity of one autolysin. Antimicrob Agents Chemother (1990) 1.26
Differentiation of Peptococcus and Peptostreptococcus by gas-liquid chromatography of cellular fatty acids and metabolic products. J Clin Microbiol (1979) 1.24
Effects of tetracycline on the streptococcal flora of periodontal pockets. Antimicrob Agents Chemother (1980) 1.22
Penicillin-netilmicin synergism against Streptococcus faecalis. Antimicrob Agents Chemother (1978) 1.19
Characterization of yellow-pigmented enterococci from severe human infections. J Clin Microbiol (1991) 1.19
Studies of cephalothin: aminoglycoside synergism against enterococci. Antimicrob Agents Chemother (1975) 1.18
Gentamicin-based medium for the isolation of group D streptococci and application of the medium to water analysis. Appl Environ Microbiol (1978) 1.18
Correlation of penicillin-induced lysis of Enterococcus faecium with saturation of essential penicillin-binding proteins and release of lipoteichoic acid. Antimicrob Agents Chemother (1990) 1.17
Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin. Antimicrob Agents Chemother (1981) 1.16
Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysis. J Clin Microbiol (2002) 1.15
Laboratory identification and epidemiology of streptococcal hospital isolates. J Clin Microbiol (1978) 1.15
Biochemical properties of CO2-dependent streptococci. J Clin Microbiol (1980) 1.14
Bacteriocin production and susceptibility among strains of Streptococcus mutans grown in the presence of sucrose. Antimicrob Agents Chemother (1974) 1.08
Neonatal sepsis caused by Streptococcus bovis variant (biotype II/2): report of a case and review. J Clin Microbiol (2003) 1.07
Evaluation of a new presumptive medium for group D streptococci. Appl Environ Microbiol (1977) 1.06
Evaluation of Pfizer selective enterococcus and KF media for recovery of fecal streptococci from water by membrane filtration. Appl Environ Microbiol (1976) 1.05
Evaluation of media for monitoring fecal streptococci in seawater. Appl Environ Microbiol (1989) 1.05
Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins. Antimicrob Agents Chemother (2001) 1.04
Sequencing and comparative genome analysis of two pathogenic Streptococcus gallolyticus subspecies: genome plasticity, adaptation and virulence. PLoS One (2011) 1.04
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics. Antimicrob Agents Chemother (1990) 1.03
The prevalence and the characterization of the enterococcus species from various clinical samples in a tertiary care hospital. J Clin Diagn Res (2012) 0.99
Bacteremia caused by viridans streptococci in 71 children. Can Med Assoc J (1981) 0.99
Routine procedures for isolation and identification of enterococci and fecal streptococci. Appl Environ Microbiol (1992) 0.99
Rapid identification of group D streptococci with the API 20S system. J Clin Microbiol (1983) 0.98
Succession of Streptococcus bovis strains with differing bacteriophage sensitivities in the rumens of two fistulated sheep. Appl Environ Microbiol (1977) 0.97
Aquatic indicator bacteria in the high alpine zone. Appl Environ Microbiol (1976) 0.96
Vancomycin-resistant enteroccus faecium and enterococcus faecalis isolated from education hospital of iran. Maedica (Buchar) (2014) 0.95
Effects of dispersed recreational activities on the microbiological quality of forest surface water. Appl Environ Microbiol (1978) 0.95
Use of Mueller-Hinton agar as amylase testing medium. J Clin Microbiol (1976) 0.92
Bile-esculin test for presumptive identification of enterococci and streptococci: effects of bile concentration, inoculation technique, and incubation time. J Clin Microbiol (1998) 0.89
Gentamicin-thallous-carbonate medium for isolation of fecal streptococci from foods. Appl Environ Microbiol (1981) 0.89
In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital. Antimicrob Agents Chemother (1987) 0.89
Antagonistic effect of penicillin-amikacin combinations against enterococci. Antimicrob Agents Chemother (1985) 0.88
Incidence of thymidine-dependent enterococci detected on Mueller-Hinton agar with low thymidine content. Antimicrob Agents Chemother (1980) 0.84
Evaluation of a rapid latex agglutination test for identification of group D streptococci. J Clin Microbiol (1984) 0.81
Cost-effective, clinically relevant method for rapid identification of beta-hemolytic streptococci and enterococci. J Clin Microbiol (1995) 0.80
Identification of Streptococcus bovis biotype I strains among S. bovis clinical isolates by PCR. J Clin Microbiol (2002) 0.79
Chocolate agar, a differential medium for gram-positive cocci. J Clin Microbiol (1984) 0.78
Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits. Antimicrob Agents Chemother (1983) 0.77
Measurement of microbial alpha-amylases with p-nitrophenyl glycosides as the substrate complex. J Clin Microbiol (1984) 0.76
Use of colony morphology to distinguish different enterococcal strains and species in mixed culture from clinical specimens. J Clin Microbiol (2003) 0.76
An Update on the Streptococcus bovis Group: Classification, Identification, and Disease Associations. J Clin Microbiol (2016) 0.75
Isolation of Streptococcus equinus from non-respiratory sources in children. J Clin Microbiol (1977) 0.75
The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis. Yale J Biol Med (1984) 0.75
Mechanism of action of BAY v 3522, a new cephalosporin with unusually good activity against enterococci. Antimicrob Agents Chemother (1991) 0.75
Constricted tube system for presumptive identification and differentiation of group D streptococci. J Clin Microbiol (1979) 0.75
Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinus. Antimicrob Agents Chemother (1982) 0.75
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci (1969) 10.08
THE GROUP D STREPTOCOCCI. Bacteriol Rev (1964) 6.73
Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00
Tetrazolium reduction as a means of differentiating Streptococcus faecalis from Streptococcus faecium. J Gen Microbiol (1956) 5.58
Streptococcus faecium var. casselifavus, nov. var. J Bacteriol (1968) 5.54
Studies on a group of previously unclassified bacteria associated with meningitis in infants. Am J Clin Pathol (1959) 4.89
PHYSIOLOGY OF THE ENTEROCOCCI AS RELATED TO THEIR TAXONOMY. J Bacteriol (1963) 4.19
Laboratory studies with a selective Enterococcus medium. Appl Microbiol (1970) 3.70
Group Q streptococci. I. Ecology, serology, physiology, and relationship to established enterococci. J Bacteriol (1967) 3.26
The identification and classification of Streptococcus faecalis and some associated streptococci. Ann Inst Pasteur Lille (1955) 3.23
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
The Enterococci: With Special Reference to Their Association with Human Disease. J Bacteriol (1947) 3.05
The influence of the growth medium on the demonstration of a group D antigen in faecal streptococci. J Gen Microbiol (1962) 2.85
Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus). Appl Microbiol (1970) 1.78
The serological grouping of Streptococcus equinus. J Gen Microbiol (1962) 1.57
[Diagnosis of group D streptococci (entercocci)]. Zentralbl Bakteriol Orig (1970) 1.51
Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17
Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23
Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01
Emergence of drug-resistant pneumococcal infections in the United States. JAMA (1994) 6.29
Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18
Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis (1991) 4.00
Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81
Changing epidemiology of group A streptococcal infection in the USA. Lancet (1990) 3.35
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26
Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16
Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Presumptive identification of group A, B, and D streptococci on agar plate media. J Clin Microbiol (1979) 2.72
Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63
Presumptive identification of streptococci with a new test system. J Clin Microbiol (1982) 2.55
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol (2001) 2.14
Specificity study of kits for detection of group A streptococci directly from throat swabs. J Clin Microbiol (1987) 2.10
Rapid identification of enterococci. J Clin Microbiol (1983) 2.03
Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother (1990) 1.93
Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis (1995) 1.93
Phenotypic and genotypic characterization of atypical Lactococcus garvieae strains isolated from water buffalos with subclinical mastitis and confirmation of L. garvieae as a senior subjective synonym of Enterococcus seriolicida. Int J Syst Bacteriol (1996) 1.92
Differentiation of Lactococcus lactis and Lactococcus garvieae from humans by comparison of whole-cell protein patterns. J Clin Microbiol (1991) 1.91
The gram positive cocci. Hum Pathol (1976) 1.90
emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology (2000) 1.89
Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J (1987) 1.89
A review of the microbiological techniques for the isolation and identification of streptococci. CRC Crit Rev Clin Lab Sci (1976) 1.84
Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol (1984) 1.81
Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains. J Clin Microbiol (1995) 1.79
Comparison of three commercial rapid identification systems for the unusual gram-positive cocci Dolosigranulum pigrum, Ignavigranum ruoffiae, and Facklamia species. J Clin Microbiol (2000) 1.78
Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Dis (1990) 1.75
Antimicrobial susceptibility patterns of Streptococcus pneumoniae. Antimicrob Agents Chemother (1978) 1.75
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Atmospheric growth requirements for Alloiococcus species and related gram-positive cocci. J Clin Microbiol (1996) 1.72
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2001) 1.69
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Enterococcus raffinosus sp. nov., Enterococcus solitarius sp. nov. and Enterococcus pseudoavium sp. nov. FEMS Microbiol Lett (1989) 1.67
Nosocomial transmission of group B streptococci. Pediatrics (1976) 1.62
Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol (1998) 1.61
Physiological characterization of nutritionally variant streptococci. J Clin Microbiol (1979) 1.57
Antimicrobial susceptibilities of Lactococcus lactis and Lactococcus garvieae and a proposed method to discriminate between them. J Clin Microbiol (1996) 1.57
Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. J Med Microbiol (1998) 1.54
Rapid group A streptococcal antigen detection kit: effect on antimicrobial therapy for acute pharyngitis. Pediatrics (1988) 1.49
Capillary precipitin typing of Streptococcus pneumoniae. J Clin Microbiol (1978) 1.47
Breast abscess associated with Helcococcus kunzii. J Clin Microbiol (1998) 1.43
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J Clin Microbiol (1997) 1.40
Globicatella sanguis gen.nov., sp.nov., a new gram-positive catalase-negative bacterium from human sources. J Appl Bacteriol (1992) 1.39
Description of Gemella sanguinis sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.35
Viridans streptococcal endocarditis: clinical, microbiological, and echocardiographic correlations. J Infect Dis (1986) 1.35
Identification of Enterococcus species and phenotypically similar Lactococcus and Vagococcus species by reverse checkerboard hybridization to chaperonin 60 gene sequences. J Clin Microbiol (2000) 1.34
Genetic relationships among the different phenotypes of Streptococcus dysgalactiae strains. Int J Syst Bacteriol (1998) 1.32
From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979. J Infect Dis (1980) 1.32
Whole-cell protein patterns of nonhemolytic group B, type Ib, streptococci isolated from humans, mice, cattle, frogs, and fish. J Clin Microbiol (1990) 1.32
Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev Infect Dis (1981) 1.30
Gemella bergeriae sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.30
Modified culture technique for Corynebacterium diphtheriae isolation from desiccated swabs. J Clin Microbiol (1978) 1.28
Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother (1981) 1.28
Evaluation of the Directigen Group A Strep test kit. J Clin Microbiol (1984) 1.26
Facklamia ignava sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.26
Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA (1996) 1.26
Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis (1992) 1.25
The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis (1990) 1.25
Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992. J Clin Microbiol (1994) 1.25
Guanidine extraction of streptococcal M protein. Infect Immun (1975) 1.25
Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics. Diagn Microbiol Infect Dis (1987) 1.25
Phenotypic characterization, cellular fatty acid composition, and DNA relatedness of aerococci and comparison to related genera. J Clin Microbiol (1990) 1.24
Recent approaches on the taxonomy of the enterococci and some related microorganisms. Adv Exp Med Biol (1997) 1.24
Enterococcus dispar sp. nov. a new Enterococcus species from human sources. Lett Appl Microbiol (1991) 1.22
Enzyme-linked immunosorbent assay for streptococcal M protein antibodies. J Clin Microbiol (1976) 1.22
Invasive pneumococcal disease in an Alaska native population, 1980 through 1986. JAMA (1989) 1.20
Wound infections due to group A streptococcus traced to a vaginal carrier. J Infect Dis (1978) 1.19
Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci. J Clin Microbiol (1998) 1.17
Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae. Clin Diagn Lab Immunol (1998) 1.16
The development by the Centers for Disease Control of a specification for streptococcal serogrouping kits and its application to Streptex and to the Phadebact Streptococcus Test. J Biol Stand (1983) 1.16
Enzyme-linked immunosorbent assay for detection of antibodies against Streptococcus pneumoniae capsular polysaccharides. J Clin Microbiol (1980) 1.15
Genotypic survey of recent beta-lactam-resistant pneumococcal nasopharyngeal isolates from asymptomatic children in Chile. J Clin Microbiol (1999) 1.14
Phenotypic and genotypic characterization of Pediococcus strains isolated from human clinical sources. J Clin Microbiol (2001) 1.13
Foodborne outbreak of group G streptococcal pharyngitis. Am J Epidemiol (1982) 1.11
New test system for identification of Aerococcus, Enterococcus, and Streptococcus species. J Clin Microbiol (1986) 1.10
Use of tests for acidification of methyl-alpha-D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera. J Clin Microbiol (1998) 1.10
Epidemiologic studies among Amerindian populations of Amazônia. I. Pyoderma: prevalence and associated pathogens. Am J Trop Med Hyg (1979) 1.10
Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis (1995) 1.08